Cell cycle progression is controlled by sequential activation of cyclin-dependent kinases (CDKs), which are often deregulated in cancer. Consequently numerous pharmacological inhibitors of CDKs have been developed with the aim of treating cancers. The article briefly reviews CDK inhibitors and their use to treat cancers, with specific focus on the use of biomarkers and drugs combination to improve their therapeutic efficacy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ceb.2013.08.004 | DOI Listing |
Publication Analysis
Top Keywords
cyclin-dependent kinases
8
targeting cyclin-dependent
4
kinases anti-neoplastic
4
anti-neoplastic therapy
4
therapy cell
4
cell cycle
4
cycle progression
4
progression controlled
4
controlled sequential
4
sequential activation
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!